Existing nucleic acid synthesis technology is error-prone and some specific sequences particularly difficult to produce. Our innovative technology has turned that on its head. Called gSynth our synthesis technology will enable a range of different applications. Using our pioneering technology, synthetic biology companies will be able to solve problems that are currently intractable.
Our technology offers:
Increased accuracy over existing Phosphoramidite synthesis processes
Improved nucleic acid synthesis (RNA, DNA and XNA) that will enable a range of different applications
Customisation to client’s tailored requirements
These advantages will enable new synthetic biology applications, including our next-generation metabolomics platform.